Categories: Market Research

Global Bone Marrow Transplantation Market Size and Forecast 2024-2033|Merck Millipore Corporation, Sanofi SA, STEMCELL Technologies Inc., HemaCare Corporation, AllCells LLC

The Bone Marrow Transplantation Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Bone Marrow Transplantation Market:

https://www.thebusinessresearchcompany.com/report/bone-marrow-transplantation-global-market-report

According to The Business Research Company’s Bone Marrow Transplantation Global Market Report 2024, The bone marrow transplantation market size has grown strongly in recent years. It will grow from $11.09 billion in 2023 to $11.75 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing prevalence of hematologic disorders, improved healthcare infrastructure, rising awareness and education, aging population, government initiatives and support.

The bone marrow transplantation market size is expected to see strong growth in the next few years. It will grow to $14.38 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to advancements in immunotherapy, increasing demand for allogeneic transplants, expanding applications in non-hematologic diseases, personalized medicine and precision therapeutics, global collaboration and partnerships. Major trends in the forecast period include technological advancements, increasing demand for allogeneic transplants, rising applications in non-malignant diseases, emergence of car-t cell therapies, enhanced pre-transplant diagnostics.

The rising prevalence of cancer and other diseases is expected to propel the growth of bone marrow transplantation going forward. Cancer is a severe disorder in which the body’s cells reproduce fast and uncontrollably, resulting in abnormal growth. A bone marrow transplant aims to cure various illnesses and cancers by infusing healthy bone marrow cells into a person after their sick bone marrow has been treated to remove the abnormal cells. It helps in curing the rising occurrence of cancer and other illnesses. For instance, in 2022, according to the reports shared by the American Cancer Society Inc., a US-based nonprofit organization, approximately 1.9 million fresh instances of cancer are projected to be diagnosed, leading to an estimated 609,360 cancer-related fatalities in the United States in 2022. Therefore, the rising prevalence of cancer and other diseases will drive the bone marrow transplantation market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=10046&type=smp

The bone marrow transplantation market covered in this report is segmented –

1) By Type: Autologous Bone Marrow Transplant, Allogenic Bone Marrow Transplant

2) By Indication: Hodgkin Lymphoma, Acute Leukaemia, Multiple Myelomas, Solid Tumours, Non-Hodgkin Lymphoma, Other Indications

3) By End-Users: Hospitals, Multispecialty Clinics, Ambulatory Surgical Centers

Technological advancements are a key trend gaining popularity in the bone marrow transplantation market. Major healthcare companies operating in the bone marrow transplantation technology market are involved in developing new and improved technology to provide their customers with new methods to sustain their position in the market. For instance, in November 2023, BioIntelliSense, a US-based health monitoring and clinical intelligence company, and UC Davis Health, a US-based hospital launched a continuous monitoring program for bone marrow transplant patients. This innovative in-hospital initiative is designed for individuals undergoing Bone Marrow Transplant and Hematology or Oncology services. The program utilizes BioIntelliSense FDA-cleared BioButton wearable devices, alongside algorithm-based data analytics and a clinical intelligence system. Its purpose is to continuously monitor subtle shifts in vital signs and detect potential signs of patient deterioration. This proactive approach enables actionable clinical decisions and timely interventions to ensure patient well-being.

The bone marrow transplantation market report table of contents includes:

1. Executive Summary

2. Bone Marrow Transplantation Market Characteristics

3. Bone Marrow Transplantation Market Trends And Strategies

4. Bone Marrow Transplantation Market – Macro Economic Scenario

5. Global Bone Marrow Transplantation Market Size and Growth

26. South America Bone Marrow Transplantation Market

27. Brazil Bone Marrow Transplantation Market

28. Middle East Bone Marrow Transplantation Market

29. Africa Bone Marrow Transplantation Market

30. Bone Marrow Transplantation Market Competitive Landscape And Company Profiles

Top Major Players: